Tejnaksh Healthcare's Half-Yearly Revenue Surpasses Previous 12-Month Period

Revenue - Half Yearly: Higher at Rs 5.83 cr than preceding 12 month period ended Mar 2024 of Rs 5.81 cr. In the half year the company has already crossed revenue of the previous twelve months.
Tejnaksh Healthcare, a microcap company in the healthcare services industry, has recently declared its financial results for the quarter ending March 2024. According to the report released on May 29, 2024, the company has shown a flat performance for the quarter. However, there has been a significant improvement in the company's overall score, which has increased from -2 to 3 in the last three months.

One of the key highlights of the financial report is the company's Profit After Tax (PAT) for the half-yearly period. The PAT for this period stands at Rs 1.04 crore, which is higher than the preceding 12-month period ending March 2024, where the PAT was Rs 1.02 crore. This indicates a positive growth trend for the company.

Another positive aspect of the financial report is the company's revenue for the half-yearly period. The revenue for this period stands at Rs 5.83 crore, which is higher than the preceding 12-month period ending March 2024, where the revenue was Rs 5.81 crore. This shows that the company has already surpassed its revenue for the previous 12 months in just half a year.

Despite these positive numbers, MarketsMOJO has given a 'Strong Sell' call for Tejnaksh Healthcare's stock. However, it is important to note that this call is based on the company's past performance and does not take into account its recent financial results. Investors are advised to do their own research and make informed decisions before investing in the company's stock.